Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model

Published:2020 Issue:3 Volume:67 Page:274-282
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Sasaki Ryo¹,Takami Taro¹²,Fujisawa Koichi³,Matsumoto Toshihiko⁴,Ishikawa Tsuyoshi¹,Yamamoto Naoki⁵,Sakaida Isao¹²³

Affiliation:

1. Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine

2. Center for Regenerative and Cell Therapy, Yamaguchi University Graduate School of Medicine

3. Department of Liver Regenerative Medicine, Yamaguchi University Graduate School of Medicine

4. Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine

5. Yamaguchi University Health Administration Center

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/67/3/67_20-88/_pdf

Reference28 articles.

1. 1 Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCl₄-induced liver fibrosis in mice. Hepatology 2004; 40: 1304–1311.

2. 2 Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292–2298.

3. 3 Iwamoto T, Terai S, Mizunaga Y, et al. Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients. J Gastroenterol 2012; 47: 300–312.

4. 4 Tanimoto H, Terai S, Taro T, et al. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 2013; 354: 717–728.

5. 5 Matsuda T, Takami T, Sasaki R, et al. A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells. Hepatol Commun 2017; 1: 691–703.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control;Stem Cells International;2022-10-07

2. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies;International Journal of Biological Sciences;2022

3. Stem Cell–Based Therapies: What Interventional Radiologists Need to Know;Seminars in Interventional Radiology;2021-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3